Acute Disease; Chronic Disease; Family Practice; Humans; Sleep Initiation and Maintenance Disorders/diagnosis; Sleep Initiation and Maintenance Disorders/etiology; Sleep Initiation and Maintenance Disorders/therapy; Anti-deppressant; Benzodiazepin; GABAergic agents; Insomnia; Pradoxal insomnia; Primary insomnia; Psychopathology traitment; Psychophyiological insomnia; Medicine (all)
Abstract :
[en] A complaint of insomnia has to be analysed, and differentiated from hypochondria and, overall, from hypersomnia. Once confirmed and assessed as acute or chronic, it is often considered a disorder of hyperarousal, that is an imbalance between a central nervous system activating and a central nervous system inhibiting system with subcontinuous overflow from the former. An acute insomnia is less than one month of duration. As a disease, insomnia has to be categorized as a secondary or a primary disorder. Thereafter, it remains to assess the extent of social, psychological and economical interactions. These factors intervene as consequences or perpetuating factors. The capacity to assess the whole situation is really the great strength of the general practitioner who, more than anybody else, is on home ground. Laboratory findings and specialist examination come only as supporting evidence for causal links. A polysomnography realized in a sleep disorder center provides data reinforcing or correcting the diagnosis. From a sound assessment of the disease, the treatment has to be deduced by following a rigorous reasoning, devoid of guilty feelings as they are suggested to patients by mass-media talking, as well as freed from fashionable non medical practices. Today, we know that chronic insomnia is a disease with potential severe consequences and that it does not heal spontaneously.
Disciplines :
Neurology
Author, co-author :
Cambron, Laurent ; Centre Hospitalier Universitaire de Liège - CHU > > Service de neurologie
Bruwier, G; Département de Médecine Générale, Université de Liège, Belgium
De Bock, I; Centre d'Etude des Troubles de l'Eveil et du Sommeil Neuropsychiatre
Poirrier, R; Service de Neurologie, CETES, CHU Sart Tilman, Liège, Belgium ; Service de Neurologie, CETES, CHU Liège, Belgium
Language :
French
Title :
Le médecin généraliste face a une plainte d'insomnie.
Alternative titles :
[en] The general practitioner and insomnia.
Publication date :
2006
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Université de Liège. Revue Médicale de Liège, Liège, Be
Descartes R.- Règles pour la direction de l'esprit (traduction et notes de J. Sirven). Vrin, Bibliothèque des Textes Philosophiques, Paris, 2003, 57-60.
International classification of sleep disorders. 2nd edition, pocket version: Diagnostic and coding manual.: American Academy of Sleep Medicine, 2006.
Pirrus R.- The FFF-LHC, a mental fatigue scale: validation and evaluation in various diseases. Personal Cog and Behav Res Ther, 2003, 2, 38-46.
Johns MW.- A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep, 1991, 14, 540-545.
Johns MW.- Sleepiness in different situations measured by the Epworth Sleepiness Scale. Sleep, 1994, 17, 703-710.
Wheatley D.- Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability. J Psychopharmacol, 2005, 19, 414-421.
Ford DE, Kamerow DB.- Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA, 1989, 262, 1479-1484.
van Hilten B, Hoff JI, Middelkoop HAM, et al.- Sleep disruption in Parkinson's disease. Arch Neurol, 1994, 51, 922-928.
Arnulf I.- Excessive daytime sleepiness in parkinsonism. Sleep Med Rev, 2005, 9, 185-200.
Diederich NJ, Vaillant M, Leischen M, et al.- Sleep apnea syndrome in Parkinson's disease. A case-control study in 49 patients. Mov Disord, 2005, 20, 1413-1418.
Gagnon JF, Bedard MA, Fantini ML, et al.- REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology, 2002, 59, 585-589.
Fleetwood-Walker SM, Hope PJ, Mitchell R.- Antinociceptive actions of descending dopaminergic tracts on cat and rat dorsal horn somatosensory neurones. J Physiol, 1988, 399, 335-348.
Perlis ML, Smith MT, Pigeon WR.- Etiology and pathophysiology of insomnia. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. Philadelphia: Elsevier Saunders, 2005, 714-725.
Bonnet MH, Arand DL.- Heart rate variability in insomniacs and matched normal sleepers. Psychosom Med, 1998, 60, 610-615.
American Psychiatric Association. Troubles du sommeil. MINI DSM-IV-TR. Critères diagnostiques (Washington DC). Traduction française par J.-D. Guelfi et al., 2004. Paris: Masson, 2000, 263-276.
Walsh JK, Roehrs T, Roth T.- Pharmacologic treatment of primary insomnia. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. Philadelphia: Elsevier Saunders, 2005, 749-760.
Rousseau JJ, Debatisse DF.- Etude clinique et polygraphique de deux observations de "nocturnal myoclonus" sensibles au Clonazépam. Acta neurol belg, 1985, 85, 318-326.
Oshtory MA, Vijayan N.- Clonazepam treatment of insomnia due to sleep myoclonus. Arch Neurol, 1980, 37, 119-120.
Montplaisir J, Allen RP, Walters AS, Ferini-Strambi L. - Restless legs syndrome and periodic limb movements during sleep. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. Philadelphia: Elsevier Saunders, 2005, 839-852.